Identification and pharmacological characterization of GV150526, a novel glycine antagonist as a potent neuroprotective agent

Drugs of the Future

Volumn 23, Issue 1, 1998, Pages 61-69

  Di Fabio, Romano ^a   Cugola, Alfredo ^a   Donati, Daniele ^a   Feriani, Aldo ^a   Gaviraghi, Giovanni ^a   Ratti, Emiliangelo ^a   Trist, David G ^a   Reggiani, Angelo ^a  

^a GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIZOCILPINE; GAVESTINEL; GLYCINE; GLYCINE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BRAIN ISCHEMIA; DRUG EFFICACY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; NEUROPROTECTION; NONHUMAN; STROKE; STRUCTURE ACTIVITY RELATION;

EID: 0031951717     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.01.442870     Document Type: Article

References (55)

1. Meldrum, B., Garthwaite, J. Excitatory amino acid neurotoxicity and neurodegenerative diseases. Trends Pharmacol Sci 1990, 11:379.
2. Choi, D.W. Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 1990, 10: 2493.
3. Meldrum, B. Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission. Cerebrovasc Brain Metab Rev 1990, 2: 27.
4. McCullogh, J. Excitatory amino acid antagonists and their potential for the treatment of ischemic brain damage in man. Br J Clin Pharmacol 1992, 34: 106.
5. Cotman, C.W., Foster, A.C., Lanthorn, T.H. An overview of glutamate as a neurotransmitter. Adv Biochem Biopharmacol 1981, 27: 1.
6. Watchins, J.C., Evans, R.H. Excitatory amino acids transmitters. Ann Rev Pharmacol Toxicol 1981, 21: 165.
7. Choi D.W., Rothman, S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Ann Rev Pharmacol Toxicol 1991, 31: 171.
8. Wong, E.H.F., Kemp, J.A. Site for antagonism on the N-methyl-D-aspartate receptor channel complex. Ann Rev Pharmacol Toxicol 1991, 31: 401.
9. Meldrum, B. (Ed.). Excitatory Amino Acid Antagonists. Blackwell: Oxford 1991.
10. Collingridge, G.L., Watkins, J.C. (Eds.). The NMDA Receptor, 2nd Ed. IRL Press: Oxford 1994.
11. Johnson, J.W., Ascher, P. Glycine potentiates the NMDA receptor response in cultured brain mouse neurones. Nature 1987, 325: 529.
12. Kleckner, N.W., Dingledine, R. Requirements for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 1988, 241: 835.
13. Thomson, A.M. Glycine is a coagonist at the NMDA receptor/ion channel complex. Prog Neurobiol 1990, 35: 53.
14. Huettner, J.E. Competitive antagonism of glycine at the N-methyl-D-aspartate (NMDA) receptor. Biochem Pharmacol 1991, 41: 9.
15. Morris, R.G.M., Anderson, E., Lynch, G.S., Baudry, M. Selective impairment of learning and blockage of long-term potentiation by an N-methyl-D-aspartate antagonist, AP5. Nature 1986, 319: 774.
16. Koek, W., Colpaert, F.C. Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phenylcyclidine-like behavioral effects. J Pharmacol Exp Ther 1990, 252: 349.
17. Chiamulera, C., Costa, S., Reggiani, A. Effect of NMDA and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning. Psychopharmacology 1990, 112: 551.
18. Palfreyman, M.G., Baron, M.B. Non-competitive NMDA antagonists acting at the glycine site. In: Excitatory Amino Acid Antagonists. Meldrum, B. (Ed.). Blackwell: Oxford 1991, 101-29.
19. Carter, A.J. Glycine antagonists: Regulation of the NMDA receptor-complex by the strychnine-insensitive glycine site. Drugs Fut 1992, 17: 595.
20. Kemp, J.A., Leeson, P.D. The glycine site of the NMDA receptor - Five years on. TIPS 1993, 14: 20.
21. Leeson, P.D., Iversen, L.L. The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential. J Med Chem 1994, 37: 4053.
22. Iversen, L.L., Kemp, J.A. Non competitive NMDA antagonists as drugs. In: The NMDA Receptor, 2nd Ed.. Collingridge, G.L., Watkins, J.C. (Eds.). IRL Press: Oxford 1994, 469-86.
23. Di Fabio, R., Gaviraghi, G., Reggiani, A. Strychnine-insensitive glycine binding site and the NMDA receptor. Chim Industria 1996, 78: 283.
24. Moore, K.W., Leeson, P.D., Carling, R.W. et al. Anticonvulsant activity of glycine-site NMDA antagonists. 1. 2-Carboxyl prodrugs of 5,7-dichlorokynurenic acid. Bioorg Med Chem Lett 1993, 3: 61.
25. Carling, R.W., Leeson, P.D., Moseley, A.M. et al. Anticonvulsant activity of glycine-site NMDA antagonists. 2. Trans 2-carboxy-4-substituted tetrahydroquinolines. Bioorg Med Chem Lett 1993, 3: 65.
26. Reggiani, A., Costa, S., Pietra, C. et al. Neuroprotective activity of GV150526A, a novel potent and selective glycine antagonist. Eur J Neurol 1995, 2: 6.
27. Pietra, C., Ziviani, L., Valerio, E., Tarter, G., Reggiani, A. Neuroprotection of GV150526A. Comparison with reference compounds. Stroke 1996, 27: 26.
28. Di Fabio, R., Cugola, A., Donati, D. et al. Novel substituted indole-2-carboxylates as potent glycine antagonists. 211th ACS Natl Meet (March 24-28, New Orleans) 1996, Abst 107.
29. Bordi, F., Pietra, C., Ziviani, L., Reggiani, A. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat. Exp Neurol 1997, 145: 425.
30. Di Fabio, R., Capelli, A.M., Conti, N. et al. Substituted indole-2-carboxylates as in vivo potent antagonists acting at the strychnine-insensitive glycine binding site. J Med Chem 1997, 40: 841.
31. Kishimoto, H., Simon, J.R., Aprison, M.H. Determination of the equilibrium dissociation constants at a number of glycine binding sites in several areas of the rat central nervous system, using a Na-independent system. J Neurochem 1981, 37: 1015.
32. Kloog, Y., Haring, R., Sokolovsky, M. Kinetic characterization of the phenylcyclidine-N-methyl-D-aspartate receptor interaction: Evidence for steric blockade of the channel. Biochemistry 1988, 27: 843.
33. Ratti, E., Tacconi, S., Graziani, F., Gaviraghi, G. Requirement of glycine for the glutamate activity at the NMDA receptor site. Eur J Pharmacol 1990, 183: 1665.
34. Van Amsterdam, F.Th.M., Giberti, A., Mugnaini, M., Ratti, E. 3-[(+)-2-Carboxypiperazin-4-yl]propyl-1-phosphonic acid recognizes two N-methyl-D-aspartate binding sites in rat cerebral cortex membranes. J Neurochem 1992, 59: 1850.
35. 3H]-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA) to rat cortex membranes reveals two sites or affinity states. J Recept Res 1991, 11: 727.
36. 3H]-kainate binding sites with different molecular target sizes in rat cortex. Neurosci Lett 1986, 65: 47.
37. Tamura, A., Graham, D.I., McCullogh, J., Teasdale, G.M. Focal cerebral ischemia in rat: 1. Description of technique and early neuropathological consequences. J Cereb Blood Flow Metab 1981, 1: 53.
38. Huettner, J.E. Indole-2-carboxylic acid: A competitive antagonist of potentiation by glycine at the NMDA receptor. Science 1989, 243: 1611.
39. Salituro, F.G., Harrison, B.L., Baron, B.M. et al. Indole derivatives: Antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex. J Med Chem 1990, 33: 2944.
40. Gray, N.M., Dappen, M.S., Cheng, B.K. et al. Novel indole-2-carboxylates as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor. J Med Chem 1991, 34: 1283.
41. Salituro, F.G., Tomlinson, R.C., Baron, B.M. et al. Design, synthesis and molecular modeling of 3-acylamino-2-carboxyindole NMDA receptor glycine site antagonists. Bioorg Med Chem Lett 1991, 1: 455.
42. Salituro, F.G., Harrison, B.L., Baron, B.M. et al. 3-(2-Carboxylindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site. J Med Chem 1992, 35: 1791.
43. Rao, T.S., Gray, N.M., Dappen, M.S. et al. Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: In vivo characterization. Neuropharmacology 1993, 32: 139.
44. Smith, E.C.R., McQuaid, L.A., Calligaro, D.O., O'Malley, P.J. Structure-activity relationship of a series of glycine antagonists related to 5,7-dichlorokynurenic acid and 3-(2-carboxy-6-chloroindol-3-yl)acetic acid. Bioorg Med Chem Lett 1993, 3: 81.
45. Leeson, P.D., Baker, R., Carling, R.W. et al. Kynurenic acid derivatives: Structure-activity relationship for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor. J Med Chem 1991, 34: 1243.
46. Leeson, P.D., Carling, R.W., Moore, K.W. et al. 4-Amino-2-carboxytetrahydroquinolines. Structure-activity relationship for antagonism at the glycine site of the NMDA receptor. J Med Chem 1992, 35: 1954.
47. Hansch, C., Leo, A. (Eds.). Substituent Constants for Correlation Analysis in Chemistry and Biology. John Wiley & Sons: London 1979.
48. Williams, S.G., Norrington, F.E. Determination of positional weighting factors for the Swain and Lupton substituent constants F and R. J Am Chem Soc 1976, 98: 508.
49. Hammett, L.P. (Ed.). Physical Organic Chemistry. McGraw-Hill: New York 1940 and 1970.
50. Draper, N.R., Smith, H. (Eds.). Applied Regression Analysis. Wiley: New York 1981.
51. RS/1 v 4.4.1. Bolt Beranek and Newman, Inc. 1992.
52. TSAR v.2.2. Oxford Molecular, Ltd. 1993.
53. Daylight v4.41. Daylight Chemical Information Systems 1995.
54. Larock, R.C. (Ed.). Comprehensive Organic Transformations. VCH Publishers: Stuttgart 1989, 972-6.
55. Di Fabio, R., Summa, V., Rossi, T. Synthesis of amides: An efficient and chemoselective method for the preparation of p-lactam derivatives related to HLE inhibitors. Tetrahedron 1993, 49: 2239 and references therein.